Merger upside masks sharp Q1 decline; execution risk is material
Revenue collapsed 17% YoY and profit 68% on project completion lumpiness, but ₹11,583 Cr of embedded contracted revenue underpins the long-term thesis. The street is unconvinced — the stock is down 45% from ATH, FII ownership has halved year-over-year, and the post-result selloff deepened through day 5 (−6.2%). Whether this reprices for real execution risk or overdoes the near-term pain hinges on H2 launches and NCLT approvals.
₹26.6 Cr
−68% YoY (OC-timing driven)
₹11,583 Cr
multi-quarter cushion
₹535 Cr
9% of FY27 target; flat YoY
₹186.62
−45% from ATH ₹339
Hubtown's Q1 tells two stories at once. Operationally, it was a collapse: revenue down 17% YoY to ₹155.6 Cr, profit down 68% YoY to ₹26.6 Cr. Structurally, it advances a long thesis: ₹11,583 Cr of pre-sales is already collected as cash and awaits project handovers (OCs) to be recognized as revenue, underpinning multi-quarter earnings visibility. The market has chosen which story to believe. The stock is down 45% from its all-time high of ₹339, FII ownership has collapsed from 3.69% to 1.48% year-over-year — institutions are exiting — and the post-result selloff actually deepened from day 1 (−0.98%) to day 5 (−6.18%). That fade is the street's verdict: the long-term thesis is acknowledged, but near-term execution risk is material, and repricing is underway.
The Q1 result: OC timing or demand weakness?
Revenue fell 17% YoY to ₹155.6 Cr. Management's defense: only three projects received their occupancy certificates (OCs) in Q1, limiting revenue recognition under RERA rules. Cash was collected long ago — ₹8,352 Cr cumulatively on ₹14,835 Cr of cumulative pre-sales — but RERA requires handover before revenue is recorded. This timing explanation is mechanically sound, but it doesn't change the headline: Q1 delivery was weak.
Pre-sales tell a softer story still. Q1 pre-sales were ₹535 Cr, flat year-over-year. Management claimed 'strong luxury demand' and robust walk-ins throughout Q1 (normally a seasonal trough), but the numbers haven't caught up. Collections were ₹320 Cr — a 3.2x ratio to pre-sales — but this reflects drawdown of money already received in prior years, not new customer conversion. In aggregate, Q1 shows cash discipline (positive for refinancing) but not yet sales traction.
The embedded pipeline: where near-term earnings live
Of ₹14,835 Cr in cumulative pre-sales, Hubtown has recognized only ₹3,252 Cr as revenue. But it has already collected ₹8,352 Cr in cash. The math: ₹8,352 Cr − ₹3,252 Cr = ₹5,100 Cr already collected but not yet handed over. Add the ₹6,483 Cr still to be collected on future handovers, and the total contracted revenue still awaiting OC/handover is ₹11,583 Cr. This is the real story of the quarter — it's not that sales are weak, it's that recognition is lumpy. Rising City Phase 1 (Ghatkopar), 25 South towers 2 & 3 (Prabhadevi), Premiere towers (Andheri West), Royale (Ahmedabad), and Northstar (Mehsana) all have OCs expected in Q2–Q4 FY27. When those handovers land, ₹2,000+ Cr of this embedded pipeline will be recognized, vindicating the embedded-revenue thesis and pushing earnings sharply higher.
Much of this revenue has already been contracted and substantially collected. It simply awaits the final milestone of handing over to the customer to be recognized as revenue in the balance sheet.
Project completion timing caused Q1 shortfall; ₹14,835 Cr pre-sales already locked
Only 3 projects had OCs in Q1. ₹11,583 Cr of pre-sales awaits Q2–Q4 OCs for revenue recognition.
Supported
Strong demand, collections ₹320 Cr in weak Q1
Collections ₹320 Cr = 3.2x pre-sales (₹535 Cr); reflects prior-year receivables drawdown, not new conversions.
Overstated
Luxury segment strong; ₹15–20k/sqft escalation in FY27
Walk-ins confirmed strong; 25 South +₹25k/sqft realized <1 year; expecting ₹15–20k/sqft more. Mid-segment muted.
Supported (luxury only)
34 MSF post-merger portfolio will drive >₹1 lakh Cr GDV
First two merger schemes have key approvals; third in regulatory progress. NCLT final sanction still pending.
Supported (aspiration, contingent)
₹2,800 Cr refinancing at lower rates underway
MD: 'refinancing options have gone up drastically', but no term sheets finalized.
Partial (unconfirmed)
What changed on this call
Merger momentum accelerated: First two schemes now have key approvals (NCLT final sanction pending); third in regulatory process
Embedded pipeline quantified: ₹11,583 Cr of ₹14,835 Cr pre-sales identified as revenue-awaiting-OC
Project OC timeline specificity improved: Rising City Phase 1, 25 South towers 2 & 3, Premiere, Royale, Northstar all flagged for FY27
FY27 guidance reaffirmed (not raised): ₹6,000 Cr pre-sales, ₹3,000 Cr collections maintained despite flat Q1 pre-sales YoY
Luxury pricing escalation documented: 25 South +₹25k/sqft realized; 25 West +₹30–40k/sqft over 1.5 years
The bull-bear ledger
₹11,583 Cr embedded revenue shields near-term P&L; multi-quarter recognition pipeline is concrete
Merger thesis compelling: 7.13 MSF → 34 MSF portfolio; >₹1 lakh Cr GDV over completion cycle
Luxury pricing power real: ₹25k/sqft realized on 25 South in <1 year; ₹15–40k/sqft escalation still in runway
Collections discipline strong: ₹8,352 Cr collected on ₹14,835 Cr pre-sales; all project cash ring-fenced to debt repayment
Debt path is clear: Target net debt-free by FY31; project-linked borrowings are self-liquidating
Q1 revenue −17% YoY, profit −68% YoY — even if OC-timing driven, it's a delivery miss
Pre-sales flat YoY despite 'strong demand' narrative contradicts traction claims
₹6,000 Cr FY27 guidance is 91% back-loaded to Q3–Q4; 5+ major launches not yet finalized or fully approved
Debt refinancing unconfirmed: ₹2,800 Cr at 14–20% cost awaits term sheets; savings quantified only as 'substantial'
FII ownership halved YoY (3.69% → 1.48%); institutional exodus signals conviction deficit
Stock down 45% from ATH; post-result fade deepened −0.98% (day 1) → −6.18% (day 5)
How the street is positioned
−0.98% (day 1)
−6.18% (day 5) — downside acceleration signals disappointment
₹186.62
vs. ATH ₹339 (−45%); below SMA200 ₹226, SMA50 ₹197, SMA20 ₹189
1.48% (Q1 FY27)
from 3.69% (Q1 FY26) — halved; institutional exit underway
₹168–₹339
Currently near lows; no cushion above current price
Risks, ranked by how much they should concern a holder
Pre-sales execution: ₹6,000 Cr guidance requires 91% in Q3–Q4 from launches not yet finalized
High25 Estates and 25 Chalets still awaiting statutory approvals. 25 Downtown Tower 5 awaiting strategic launch timing. If approvals slip or launch momentum disappoints, guidance misses and credibility collapses further.
Project OC (completion certificate) timing uncertainty
HighOC delays of 1–2 months shift ₹2,000+ Cr revenue recognition to next quarter. Earnings remain lumpy; quarterly run-rate visibility is false, making P&L unreliable for forecasting.
Debt refinancing unconfirmed
Medium₹2,800 Cr at 14–20% cost awaits term sheets. If refinancing stalls, interest burden remains high; ROE (currently <10%) stays depressed; refinancing savings remain a mirage.
Merger NCLT approval delays
MediumFirst two schemes have key approvals but still need NCLT final sanction. Third scheme still in regulatory pipeline. Delays postpone 34 MSF portfolio expansion and >₹1 lakh Cr GDV realization by 6–12 months.
Luxury segment concentration and macro exposure
MediumQ1 sales driven entirely by luxury (mid-segment muted). If HNI sentiment sours (equity market downturn, global headwinds), pricing power and walk-in quality deteriorate; pricing escalation plans evaporate.
What to watch next
1 · Q2–Q3 FY27: OCs from 25 South, Rising City, Premiere unlock ~₹2,000 Cr revenue
This is the 'proof of embedded pipeline' moment. If OCs land on time and revenue recognition jumps Q2–Q3, the thesis is vindicated and the stock re-rates sharply higher. If OCs slip, more quarters of lumpy earnings and the stock risks re-testing lows.
2 · Q3–Q4 FY27: Launch success of 5+ major projects (25 Downtown Tower 5, 25 Estates, 25 Chalets, Chembur Phase 2)
These launches must fire to hit ₹6,000 Cr pre-sales target. If even one slips or market uptake is tepid, the full-year guidance misses by ₹1,000+ Cr. This is the inflection that separates oversold from value trap.
3 · Oct–Nov 2026: 25 Downtown upper-floor (51–85) sale opens; pricing power tested
Management expects ₹15–20k/sqft escalation on higher floors. If walk-ins and conversion remain strong at premium prices, luxury thesis holds. If uptake is tepid, pricing power is weaker than claimed and FY27 pre-sales guidance is at risk.
4 · Q4 FY27 / H1 FY28: NCLT final approval for all three merger schemes
If delayed into FY28, the portfolio expansion and >₹1 lakh Cr GDV target slip by 6+ months. This is a structural re-rating upside if confirmed on time or a disappointment if stalled.
5 · H2 FY27: Debt refinancing term sheets finalized
Management must move from 'options have improved' to signed commitments. If refinancing closes at 200–300bp lower rate, ROE could jump to 10–12% and materially improve the investment case. If stalled, debt cost pressure continues.
The honest read
Hubtown is caught in a classic tension between long-term structural strength and near-term execution risk. The long-term case is sound: ₹11,583 Cr of embedded contracted revenue is real and will be recognized over the next 2–4 quarters; the 34-MSF post-merger portfolio is transformational; luxury micro-markets (South Mumbai, Bandra, Prabhadevi) have structural pricing power and sticky HNI demand. But the near-term path is narrow and risky. Q1 revenue and profit both missed badly (−17% and −68% YoY), pre-sales are flat despite a 'strong demand' narrative, and the full-year ₹6,000 Cr pre-sales guidance is 91% dependent on Q3–Q4 launches that are not yet finalized. Most damning, the street has lost patience: the stock is down 45% from its peak, FII ownership has halved, and the post-result selloff accelerated through day 5.
This is not a simple value trap. Rather, it's an execution binary. If management closes H2 launches on time, NCLT approvals hold, OCs land in Q2–Q3, and debt refinancing closes by year-end, the stock is likely oversold and will re-rate 30–50% higher. But if any pillar cracks — if 25 Estates approvals delay, if NCLT hits roadblocks, if pre-sales momentum stays flat into Q2–Q3, or if refinancing remains unsigned — then the embedded pipeline thesis is pushed into FY28, earnings remain lumpy, and the stock could easily revisit the 52-week low of ₹168.
The number to track is pre-sales in Q2–Q3 FY27. If combined Q2–Q3 pre-sales exceed ₹3,000 Cr (showing momentum into the big H2 launches), the bear case is fading and the stock has room to recover. If they stay under ₹2,500 Cr, the ₹6,000 Cr full-year guidance is likely to miss by ₹1,000+ Cr, and the stock will stay under pressure. That one metric tells you whether the street's 45% repricing is overdone (opportunity) or justified (trap).
Hubtown's Q1 collapse is real, the merger upside is compelling, but the execution pathway is narrow and risky. The market is pricing for near-term pain; whether that repricing is overdone or justified hinges on H2 launches, NCLT timelines, and refinancing progress. Hold, with conviction tied to Q2–Q3 pre-sales momentum. The stock is down 45% and the institutions have exited — if execution holds, this is a rebound opportunity. If it doesn't, you're owning structural upside with near-term binary risk that's not yet priced in the downside.
Hubtown Q1 FY27: consolidated PAT falls 68% YoY to ₹26.6 Cr as margins compress
PAT -67.68% YoY · revenue -16.97% · margins compressing
₹155.62 Cr
-16.97% YoY
₹26.58 Cr
-67.68% YoY
13.13%
-21.8pp YoY
₹1.75
Hubtown's consolidated PAT for the quarter ended June 30, 2026 came in at ₹26.58 Cr, down 67.7% from ₹82.21 Cr a year ago, while revenue from operations fell a smaller 17.0% YoY to ₹155.62 Cr from ₹187.41 Cr — profit contracted far faster than revenue, the hallmark of a margin-compression quarter rather than a simple volume slowdown. Sequentially the picture looks steadier (PAT +1.4% QoQ, revenue -2.7% QoQ versus Q4 FY26), but the company itself cautions that real-estate revenue recognition is lumpy and quarter-to-quarter comparisons are not representative of underlying profitability, so the YoY read is the one that matters here.
Q1 FY-2027 vs prior quarters
The margin bridge shows the squeeze clearly: consolidated net margin fell to 13.1% of total income from 34.98% a year ago, and operating margin (revenue from operations less operating costs, ex-finance and depreciation) fell to 18.3% from 21.75%. Finance costs consolidated rose to ₹41.78 Cr from ₹15.57 Cr YoY even before accounting for the ₹5.28 Cr of ICD interest the company still has not provided for this quarter — the second consecutive period flagged with this qualification by auditors JBTM & Associates (FY26 full-year unprovided interest was ₹17.52 Cr). Management says it has settled with one major private lender on this and is pursuing similar terms with others, but until resolved the reported profit for both standalone and consolidated results is somewhat overstated relative to full provisioning.
The stock went into the print at ₹190.51, down 10.5% over the past month of trading.
For context: PAT has now risen for 2 consecutive quarters.
What the summary numbers don't show
Basic EPS ₹1.75 consolidated (vs ₹5.85 YoY) and ₹1.25 standalone (vs ₹4.96 YoY).
Hubtown Limited anticipates significant revenue recognition from project completions in the current year, projecting approximately 6,000 crores in pre-sales and 3,000 crores in collections for FY27. Management plans to utilize surpluses primarily for high-cost debt repayment, with ongoing efforts to secure lower-cost c
No consensus estimates for this print were found in a web search, so vs-street stands unknown; there was likewise no formal quarterly guidance to check against — the only outlook on record from the Q4 FY26 concall was a full-year FY27 target of roughly ₹6,000 Cr in pre-sales and ₹3,000 Cr in collections, with surpluses earmarked for high-cost debt repayment. A single quarter's revenue decline doesn't confirm or contradict a four-quarter target, but it offers no early evidence of the anticipated ramp either. No management press release accompanied this filing, so framing rests on the results and audit note alone. The same board meeting also approved a plan to raise up to US$150 million via optionally convertible FCCBs on a private-placement basis — pricing, tenure and listing venue are still to be finalised — which lines up with the stated intent to retire high-cost debt, and follows a June 23 shareholder approval to merge two subsidiaries into the group structure.
W1
Whether the ₹5.28 Cr of unprovided ICD interest gets settled or provided for in Q2, per management's statement that it is 'hopeful of amicable settlements with other lenders shortly.'
W2
Terms, pricing and progress of the up-to-US$150 million FCCB issuance approved this quarter, earmarked for high-cost debt repayment.
W3
Whether revenue and pre-sales trend toward the FY27 target of ~₹6,000 Cr pre-sales/₹3,000 Cr collections in coming quarters, given Q1 revenue fell 17% YoY rather than showing the anticipated project-completion ramp.
Consolidated PAT (₹26.58 Cr) = PBT-tax (₹26.62 Cr) plus share of associates/JV loss (-₹0.04 Cr), consistent with prior-quarter/year-ago methodology in our records. Both periods carry a qualified limited-review opinion: ₹528.48 Lakh (₹5.28 Cr) of interest on inter-corporate deposits was not provided in the current quarter, understating finance cost and overstating profit by that amount (standalone and consolidated). No exceptional items in either period.
Merger upside masks sharp Q1 decline; execution path tight
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Guided ₹6k Cr pre-sales, ₹3k Cr collections for FY27; reaffirmed both this call. Q1 pre-sales ₹535 Cr vs assumed ~₹600 Cr pro-rata — flat YoY signals slower market uptake than prior guidance assumed.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Hubtown is caught between structural strength (₹11.6 Cr embedded revenue, luxury pricing power, 34 MSF post-merger) and execution urgency (Q1 PAT -68%, pre-sales flat YoY, ₹6k Cr target 91% back-loaded to H2, refinancing unconfirmed). The merger thesis is compelling long-term, but near-term delivery is at risk.
₹155.6 Cr
Revenue · −17% YoY₹26.6 Cr
Reported PAT · −67.7% YoYFlat
Margins · vs guidance: MixedDid the claims hold up?
Project completion method caused Q1 revenue shortfall; 14,835 Cr pre-sales already locked
MET₹156 Cr Q1 revenue -17% YoY due to limited OCs. Pre-sales ₹535 Cr Q1 (flat YoY area). Contracted pipeline ₹11,583 Cr awaits OC/handover.
Strong demand, collections ₹320 Cr in weak Q1 quarter
OVERSTATEDCollections ₹320 Cr is 3.2x pre-sales (₹535 Cr), confirming prior-year receivables drawdown. Not new demand signal.
Luxury segment strong; 25 Downtown upper floors get ₹15-20k/sqft escalation this year
METWalk-ins confirmed strong for luxury; mid-segment muted. Price escalation cited but not yet achieved ('this year we see…scope'). Stock market headwinds acknowledged as dampener H1.
34 MSF future pipeline + merger will drive >₹1 lakh Cr GDV
METPortfolio expands 7.13 MSF → 34 MSF post-merger (approved in principle, NCLT approvals pending). GDV >₹1 lakh Cr is aspiration, not committed timeline.
Debt refinancing ₹2,800 Cr at lower rates underway
PartialMD stated 'refinancing options have gone up drastically', but no term sheets finalized ('till we have final term sheets, we cannot make any cash work'). Savings quantified as 'substantial' only.
Earnings quality
What changed since the last call
Merger (Hubtown 2.0) advanced to key approvals stage
UpgradeFirst two merger schemes now have key approvals, awaiting NCLT sanction. Third scheme in progress. Portfolio will expand from 7.13 MSF to 34 MSF, supported by 347 acres.
Quantified embedded contracted pipeline disclosed
New₹11,583 Cr of ₹14,835 Cr total pre-sales already collected but not yet recognized as revenue (₹3,252 Cr recognized to date). Represents multi-quarter revenue visibility.
Project completion timeline specificity improved
UpgradeIdentified OC expectations: 25 South (2 towers in FY27, 1 in Mar '27), Rising City Phase 1, Premiere, Royale (Ahmedabad), Northstar (Mehsana) all in FY27. De-risks revenue recognition vs vague prior guidance.
Pre-sales guidance reaffirmed despite flat Q1 YoY
Maintained₹6,000 Cr pre-sales FY27 maintained; ₹3,000 Cr collections maintained. No cut or raise, but Q1 ₹535 Cr (flat YoY, only 9% of target) puts H2 execution pressure very high.
Luxury pricing escalation documented, mid-segment soft
New25 South: +₹25k/sqft in <1yr, expecting another ₹15-20k/sqft. 25 West: +₹30-40k/sqft in 1.5yr. But mid-segment walk-ins muted; mix shift to luxury only.
The Q&A
Analysts pressed on refinancing timelines (no term sheets), low ROE (acknowledged, pinned to debt cost + deliveries), flat pre-sales YoY (deflected to H2 launches), and collections decline from prior Q1 (linked to project timing, not demand). Management held line on ₹6k/₹3k guidance but offered little new quantification on refinancing savings or OC timing certainty.
25 Downtown upper-floor sale timing — Deepak, analyst
AnsweredStrategically opened very shortly (Oct onwards) to maximize price on higher floors; enhanced revenue per flat targeted.
New project launches FY27 — Deepak, analyst
Partial25 Estates Q4 FY27 (awaiting statutory approvals). 25 Chalets Q4 FY27 (advanced planning). 25 Downtown Tower 5 Oct-Nov 2026 (awaiting strategic launch). 25 West timing not stated.
OC expectations FY27 — Deepak, analyst
AnsweredRising City Phase 1 (Ghatkopar), 25 South towers 2 & 3 (North & Central), Premiere Tower 1C (Bel Air, Andheri), Royale (Ahmedabad), Northstar (Mehsana) buildings.
High-cost debt refinancing progress — Deepesh Sancheti, Maanya Finance
PartialRefinancing options gone up drastically; exploring options on ₹2,800 Cr (14-20% cost). Substantial savings expected but no term sheets finalized yet; cannot commit timing.
Debt quantum & expected savings — Deepesh Sancheti, Maanya Finance
Dodged₹2,800 Cr portfolio at 14-20% cost targeted for refinancing. Cannot quantify savings yet without term sheets.
Capital allocation: debt repayment vs new capex — Deepesh Sancheti, Maanya Finance
AnsweredAll surpluses ring-fenced by project; cash from each project goes to repay project debt only. No cross-project redeployment until debts cleared.
Fundraise plans (preferential/QIP/FCCB) — Deepesh Sancheti, Maanya Finance
PartialYes, enabling resolutions in place (preferential/QIP/FCCB). Awaiting right time to launch; no timeline given.
FY27 growth drivers post-merger — Deepesh Sancheti, Maanya Finance
Answered30+ MSF existing portfolio sufficient for next 2-3 years. New projects will come but on partnership basis (capital light) vs owned development.
25 South / 25 Downtown price escalation scope — Deepesh Sancheti, Maanya Finance
Answered25 South: +₹25k/sqft achieved in <1yr; expect another ₹15-20k/sqft rise. 25 Downtown: scope for ₹15-20k/sqft within year on higher floors. 25 West: +₹30-40k/sqft over 1.5yr.
Luxury vs mid-segment demand — Deepesh Sancheti, Maanya Finance
AnsweredLuxury side no demand slowdown despite stock market/global headwinds H1. Bookings, collections, walk-ins solid and strong. Good pipeline. Mid-segment relatively muted.
Post-merger total GDV — Darshil Pandya, Finterest Capital
PartialExpect to exceed ₹1 lakh crores over period as projects complete.
Promoter holding post-merger — Darshil Pandya, Finterest Capital
AnsweredRange of around 68% post-merger.
FY27 pre-sales guidance & new launch contribution — Akshay Sharma, Abakkus
Answered₹6,000 Cr pre-sales guidance. Major chunk from 25 Downtown Tower 5. ~₹500 Cr from 25 Chalets (Thane). ~₹500 Cr from 25 Estates. ~₹300-400 Cr from Chembur Phase 2.
Annuity portfolio / commercial rental income timeline — Mokshang Sanghavi, BSC Advisors
AnsweredCommercial assets launch shortly in 1-2 projects, completed over 2-3 years. Annuity portfolio / rental income flows into Hubtown financials ~2.5 years onward.
Inventory position & price-pass-through ability — Mokshang Sanghavi, BSC Advisors
PartialGetting good traction on price escalation; expect situation to continue for next 2 years. (Referenced prior answer on pricing.)
FCCB fundraise (USD 150M, ~₹1,400 Cr) timeline & tranche structure — Mokshang Sanghavi, BSC Advisors
PartialPreferably single tranche with commitments flowing in. Waiting for markets to improve before launch.
Pre-sales Q1 vs Q1 YoY; flatness despite 'strong market' narrative — Niraj, investor
PartialPre-sales timing driven by launch cadence, typically H2 weighted. Will see uptick in later half of FY27.
FY27 pre-sales target timing: when does ₹6,000 Cr get booked? — Niraj, investor
AnsweredLargely Q3 and Q4 FY27. Launch timing of Thane, new homes (25 Estates), Chembur planned for Q3-Q4.
Collections trend: Q1 '27 decline vs Q1 '26; linkage to pre-sales or completion? — Niraj, investor
AnsweredCollections linked to construction progress & project completions (RERA mandate). This year expect collections from 25 South, 25 West, Ghatkopar completions (Q2-Q4). Collections start when plinth comes up (Q2-Q3). Target ₹3,000 Cr FY27.
Q1 sales breakdown by segment/geography — Deepesh Sancheti, Maanya Finance (follow-up)
AnsweredMainly luxury segment drove sales. Collections from completed projects (Ghatkopar & 25 South).
Sales mix consistency FY27 — Deepesh Sancheti, Maanya Finance (follow-up)
AnsweredYes, expect same trend to continue for FY27.
ROE persistently low (<10%); improvement plan — Deepesh Sancheti, Maanya Finance (follow-up)
PartialWorking on refinancing at lower rate (work started, will reflect in ROE). Prices increasing, deliveries happening; ROEs bound to improve.
Rental/annuity revenue contribution forward — Deepesh Sancheti, Maanya Finance (follow-up)
AnsweredNo rental revenue expected next 2 years. Planning commercial projects (rent vs sale). Completion over 2-2.5-3 years; rental income starts post that.
Promoter share pledge status & removal timeline — Deepesh Sancheti, Maanya Finance (follow-up)
AnsweredTwo pledges continuing; planning to get released. Expect removal by FY27. All pledges in company history only for funds to Hubtown (collateral, not personal use).
Walk-in quality & conversion trends Q1-Q2 luxury — Mokshang Sanghvi, BSC Advisors (follow-up)
AnsweredWalk-ins very strong throughout Q1 (typically lull period). Strong luxury walk-ins. Mid-segment (Ghatkopar, Andheri) muted. Walk-in quality very good.
Long-term geographic strategy: MMR-centric vs diversification — Mokshang Sanghvi, BSC Advisors (follow-up)
AnsweredPolicy: will concentrate on MMR for next few years.
Guidance
FY27 pre-sales ₹6,000 Cr (vs Q1 ₹535 Cr recorded, 9% of target)
MediumHeavily dependent on Q3-Q4 project launches (25 Downtown Tower 5, 25 Estates, 25 Chalets, Chembur Phase 2, etc.). Only 9% achieved in Q1; 91% back-loaded to H2.
FY27 collections ₹3,000 Cr (vs Q1 ₹320 Cr)
MediumLinked to construction progress (RERA mandate). Expected from 25 South, 25 West, Ghatkopar, Chembur completions Q2-Q4.
OPM likely to improve post-refinancing & price escalation
LowManagement cited refinancing ₹2,800 Cr (14-20% cost) as margin driver, but no term sheets finalized. Price escalation momentum acknowledged but quantification vague.
ROE to improve as debt refinancing closes & deliveries increase
LowHistor ROE <10% acknowledged as concern. Improvement dependent on refinancing execution (uncertain) and margin expansion (not yet visible in Q1).
New launches Q3-Q4 FY27 (25 Estates, 25 Chalets, Chembur Phase 2) financed via collections + partnership capital
Medium25 Estates & 25 Chalets awaiting statutory approvals (expected within FY27). Chembur Phase 2 already cleared. New projects on partnership basis (capital light) vs owned development.
FCCB fundraise of ₹1,400 Cr (~USD 150M) pending but timing uncertain
LowEnabling resolution in place; awaiting 'right time' to launch. No quantified capex plan tied to this.
Risks the call surfaced
Project completion timing
HighRevenue recognition tied to OC receipt + customer handover. Q1 ₹156 Cr reflects only 3 projects with OCs. Next major OCs (25 South towers, Rising City) expected Q2-Q4 FY27, but any slip delays recognition to next quarter.
Debt refinancing execution
Medium₹2,800 Cr portfolio at 14-20% cost awaits refinancing. Management claims 'refinancing options have gone up drastically' and expects 'substantial savings', but no term sheets finalized. If refinancing fails or delays, high debt cost persists; ROE stays <10%.
Merger regulatory approval
MediumThree merger schemes underway. First two have key approvals, awaiting NCLT final sanction. Third still in regulatory approval process. If any scheme stalls or is rejected, planned portfolio expansion (7.13 MSF → 34 MSF) is delayed; >₹1 lakh Cr GDV target pushed back.
Pre-sales execution & back-loading
HighFY27 ₹6,000 Cr pre-sales guidance requires 91% realization in H2 (Q3-Q4). Q1 only ₹535 Cr (flat YoY). Dependent on 5+ new project launches (25 Downtown Tower 5, 25 Estates, 25 Chalets, Chembur Phase 2, etc.). If launches slip, approvals delay, or market sentiment softens, ₹6,000 Cr target at risk.
Luxury segment concentration & macro sensitivity
MediumQ1 sales driven mainly by luxury segment; mid-segment walk-ins muted. Luxury is exposed to HNI sentiment, stock market volatility, global macro. Khilen acknowledged 'stock market headwinds' as H1 price-rise dampener. If broader macro downturn occurs, luxury demand & pricing power could evaporate.
Promoter share pledge
LowTwo pledges on promoter shares continuing as of Q1 FY27. Management states pledges taken only for collateral to company (not personal use) and plans to release by FY27. However, any liquidation risk or covenant breach could trigger forced selling.
Management
Score 7/10. Clear on strategy (Hubtown 2.0, embedded pipeline, project timeline specificity). Transparent on challenges (debt cost, refinancing uncertainty, Q1 weakness due to OC timing). Specific on project OC expectations and pricing escalation. Less candid on refinancing quantum/timing and ROE improvement path. Track record mixed: Q1 revenue -17% YoY (miss on quarterly delivery), but pre-sales ₹14.8 Cr cumulative achieved (validation of prior guidance). Merger on track (2 schemes have key approvals). Price escalation realized (25 South +₹25k/sqft, 25 West +₹30-40k/sqft). Collections discipline maintained (all project cash to debt repayment).
1 · Q2–Q3 FY27
25 South tower 2 & final tower OCs unlock ~₹2,000 Cr revenue recognition
2 · Q3–Q4 FY27
5 major project launches (25 Downtown Tower 5, 25 Estates, 25 Chalets, Chembur Phase 2, etc.) driving ₹5.5 Cr pre-sales
3 · Oct-Nov 2026
25 Downtown upper-floor (51-85) sale opens strategically; pricing power tested
The merger thesis is compelling long-term, but near-term delivery is at risk.